Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12

Journal of Virology

Volumn 83, Issue 6, 2009, Pages 2663-2674

  Crettaz, Julien ^a   Otano, Itziar ^a   Ochoa, Laura ^a   Benito, Alberto ^b   Paneda, Astrid ^a   Aurrekoetxea, Igor ^a   Berraondo, Pedro ^a   Rodríguez Madoz, Juan Roberto ^a   Astudillo, Aurora ^c   Kreppel, Florian ^d   Kochanek, Stefan ^d   Ruiz, Juan ^e   Menne, Stephan ^f   Prieto, Jesus ^a,b   Gonzalez Aseguinolaza, Gloria ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d UNIVERSITY OF ULM   (Germany)

^e Digna Biotech   (Spain)

^f Animal Health Diagnostic Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; INTERLEUKIN 12; MEMBRANE ANTIGEN; MIFEPRISTONE; TRANSCRIPTION FACTOR FOXP3; VIRUS ANTIGEN; VIRUS DNA; FORKHEAD TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INTERFERON PRODUCTION; LIVER HISTOLOGY; LYMPHOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TREATMENT RESPONSE; UPREGULATION; VIREMIA; VIRUS GENOME; VIRUS LOAD; WOODCHUCK; ADENOVIRUS; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; DNA SEQUENCE; GENE VECTOR; GENETICS; IMMUNOLOGY; LIVER; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; SCIURIDAE; VIROLOGY;

ANIMALIA; HEPADNAVIRIDAE; HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS VIRUS;

ADENOVIRIDAE; ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GENE THERAPY; GENETIC VECTORS; HEPATITIS B; HEPATITIS B VIRUS, WOODCHUCK; INTERFERON-GAMMA; INTERLEUKIN-12; LIVER; MARMOTA; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; VIREMIA;

EID: 62749092550     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02384-08     Document Type: Article

References (33)

1. Barboza, L., S. Salmen, L. Goncalves, M. Colmenares, D. Peterson, H. Montes, R. Cartagirone, M. C. Gutierrez, and L. Berrueta. 2007. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 368:41-49.
2. Berraondo, P., L. Ochoa, J. Crettaz, F. Rotellar, A. Vales, E. Martinez-Anso, M. Zaratiegui, J. Ruiz, G. Gonzalez-Aseguinolaza, and J. Prieto. 2005. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intra-portal or intramuscular routes. Mol. Ther. 12:68-76.
3. Bertoletti, A., and A. J. Gehring. 2006. The immune response during hepatitis B virus infection. J. Gen. Virol. 87:1439-1449.
4. Boni, C., A. Bertoletti, A. Penna, A. Cavalli, M. Pilli, S. Urbani, P. Scog-namiglio, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Investig. 102:968-975.
5. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, A. Bertoletti, and C. Ferrari. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225.
6. Boni, C., A Penna, G. S. Ogg, A. Bertoletti, M. Pilli, C. Cavallo, A. Cavalli, S. Urbani, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 2001. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963-971.
7. Carreno, V., S. Zeuzem, U. Hopf, P. Marcellin, W. G. Cooksley, J. Fevery, M. Diago, R. Reddy, M. Peters, K. Rittweger, A. Rakhit, and M. Pardo. 2000. A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J. Hepatol. 32:317-324.
8. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71:3236-3243.
9. Crettaz, J., P. Berraondo, I. Mauleon, L. Ochoa, V. Shankar, M. Barajas, N. van Rooijen, S. Kochanek, C. Qian, J. Prieto, R. Hernández-Alcoceba, and G. Gonzalez-Aseguinolaza. 2006. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice. Hepatology 44:623-632.
10. + regulatory T cells. Nat. Immunol. 4:330-336.
11. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
12. Gujar, S. A., A. K. Jenkins, C. S. Guy, J. Wang, and T. I. Michalak. 2008. Aberrant lymphocyte activation precedes delayed virus-specific T-cell response after both primary infection and secondary exposure to hepadnaviras in the woodchuck model of hepatitis B virus infection. J. Virol. 82:6992-7008.
13. Kochanek, S., G. Schiedner, and C. Volpers. 2001. High-capacity 'gutless' adenoviral vectors. Curr. Opin. Mol. Ther. 3:454-463.
14. Kreppel, F., T. T. Luther, I. Semkova, U. Schraermeyer, and S. Kochanek. 2002. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector. Investig. Ophthalmol. Vis. Sci. 43:1965-1970.
15. Lohr, H. F., S. Pingel, W. O. Bocher, H. Bernhard, S. Herzog-Hauff, S. Rose-John, and P. R. Galle. 2002. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleukin-12. Clin. Exp. Immunol. 130:107-114.
16. Lok, A. S. 2007. Navigating the maze of hepatitis B treatments. Gastroen-terology 132:1586-1594.
17. Maier, H., M. Isogawa, G. J. Freeman, and F. V. Chisari. 2007. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J. Immunol. 178:2714- 2720.
18. Menne, S., and P. J. Cote. 2007. The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J. Gastroenterology 13:104-124.
19. Menne, S., B. C. Tennant, J. L. Gerin, and P. J. Cote. 2007. Chemo-immu-notherapy of chronic hepatitis B virus infection in the woodchuck model breaks immunologic tolerance and restores T-cell responses to PreS and S regions of the viral envelope protein. J. Virol. 51:3177-3184.
20. Rakhit, A., M. M. Yeon, J. Ferrante, S. Fettner, R. Nadeau, R. Motzer, R. Bukowski, D. M. Carvajal, V. L. Wilkinson, D. H. Presky, J. Magram, and M. K. Gately. 1999. Down-regulation of the pharmacokinetic-pharmacody-namic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice. Clin. Pharmacol. Ther. 65:615-629.
21. Rigopoulou, E. I., D. Suri, S. Chokshi, I. Mullerova, S. Rice, R. S. Tedder, R. Williams, and N. V. Naoumov. 2005. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42:1028-1036.
22. Rossol, S., G. Marinos, P. Carucci, M. V. Singer, R. Williams, and N. V. Naoumov. 1997. Interleukin-12 induction of Thl cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Investig. 99:3025-3033.
23. Rushbrook, S. M., M. Hoare, and G. J. Alexander. 2007. T-regulatory lymphocytes and chronic viral hepatitis. Exp. Opin. Biol. Ther. 7:1689-1703.
24. Schlaak, J. F., G. Tully, H. F. Lohr, G. Gerken, and K. H. Meyer zum Biischenfelde. 1999. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J. Hepatol. 30:353-358.
25. Singh, M, A. Dicaire, A. E. Wakil, C. Luscombe, and S. L. Sacks. 2004. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J. Virol. Methods 118:159-167.
26. Stoop, J. N., R. G. van der Molen, C. C. Baan, L. J. van der Laan, E. J. Kuipers, J. G. Kusters, and H. L. Janssen. 2005. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41:771-778.
27. Stoop, J. N., R. G. van der Molen, E. J. Kuipers, J. G. Kusters, and H. L. Janssen. 2007. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 361:141-148.
28. Thio, C. L., T. L. Mosbruger, R. A. Kaslow, C. L. Karp, S. A. Strathdee, D. Vlahov, S. J. O'Brien, J. Astemborski, and D. L. Thomas. 2004. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J. Virol. 78:11258-11262.
29. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
30. Wang, L., R. Hernandez-Alcoceba, V. Shankar, M. Zabala, S. Kochanek, B. Sangro, M. G. Kramer, J. Prieto, and C. Qian. 2004. Prolonged and induc-ible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Gastroenterology 126:278-289.
31. Xiong, S. Q., B. L. Lin, X. Gao, H. Tang, and C. Y. Wu. 2007. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers. Int. Immunopharmacol. 7:578-587.
32. Yuan, H. J., and W. M. Lee. 2007. Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B. Curr. Mol. Med. 7:185-197.
33. Zhou, T., J. T. Guo, F. A. Nunes, K. L. Molnar-Kimber, J. M. Wilson, C. E. Aldrich, J. Saputelli, S. Litwin, L. D. Condreay, C. Seeger, and W.S. Mason. 2000. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J. Virol. 74: 11754-11763.